Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Nebojsa Lalić"'
Autor:
Stefan Dugalic, Milos Petronijevic, Brankica Vasiljevic, Jovana Todorovic, Dejana Stanisavljevic, Aleksandra Jotic, Ljiljana Lukic, Tanja Milicic, Nebojsa Lalić, Katarina Lalic, Milica Stoiljkovic, Zorica Terzic-Supic, Tamara Stanisavljevic, Aleksandar Stefanovic, Katarina Stefanovic, Svetlana Vrzic-Petronijevic, Maja Macura, Igor Pantic, Pavle Piperac, Marija Jovanovic, Radmila Cerovic, Sinisa Djurasevic, Sandra Babic, Sonja Perkovic-Kepeci, Miroslava Gojnic
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 19; Issue 11; Pages: 6517
The aim of this study was to analyze the trends in diabetes in pregnancy in Belgrade, Serbia for the period of the past decade and forecast the number of women with pre-gestational diabetes for the years 2030 and 2050. The study included the data on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fb844fb03de35a124263c3c3cf8c9c8
https://pubmed.ncbi.nlm.nih.gov/35682099
https://pubmed.ncbi.nlm.nih.gov/35682099
Autor:
Antonio Ceriello, Helena W. Rodbard, Tadej Battelino, Frank Brosius, Francesco Cosentino, Jennifer Green, Linong Ji, Monika Kellerer, Susan Koob, Mikhail Kosiborod, Nebojsa Lalic, Nikolaus Marx, T. Prashant Nedungadi, Christopher G. Parkin, Lars Rydén, Wayne Huey-Herng Sheu, Eberhard Standl, Per Olav Vandvik, Oliver Schnell, for the Taskforce of the Guideline Workshop
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-5 (2023)
Abstract In recent years, several novel agents have become available to treat individuals with type 2 diabetes (T2D), such as sodium-glucose cotransporter-2 inhibitors (SGLT-2i), tirzepatide, which is a dual glucose-dependent insulinotropic polypepti
Externí odkaz:
https://doaj.org/article/27d5cfd5c6c14083a4d8c6448166a500
Autor:
Oliver Schnell, Tadej Battelino, Richard Bergenstal, Matthias Blüher, Michael Böhm, Frank Brosius, Richard D. Carr, Antonio Ceriello, Thomas Forst, Francesco Giorgino, Bruno Guerci, Hiddo J. L. Heerspink, Baruch Itzhak, Linong Ji, Mikhail Kosiborod, Nebojša Lalić, Michael Lehrke, Nikolaus Marx, Michael Nauck, Helena W. Rodbard, Giuseppe M. C. Rosano, Peter Rossing, Lars Rydén, Francesca Santilli, Petra-Maria Schumm-Draeger, Per Olav Vandvik, Tina Vilsbøll, Christoph Wanner, Carol Wysham, Eberhard Standl
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-16 (2022)
Abstract The 7th Cardiovascular Outcome Trial (CVOT) Summit on Cardiovascular, Renal, and Glycemic Outcomes, was held virtually on November 18–19, 2021. Pursuing the tradition of the previous summits, this reference congress served as a platform fo
Externí odkaz:
https://doaj.org/article/00e116eff4ae44ebb18f8fbed0bc075e
Autor:
Vladimir, Kanjuh, Miodrag, Ostojić, Nebojsa, Lalić, Edita, Stokić, Nada, Adić-Cemerlić, Nikolai N, Anitschkow
Publikováno v:
Medicinski pregled. 62
After reviewing the general characteristics of lipids (LDL-C, VLDL-C, HDL-C) and atherothrombosis, including the I-VIII degrees of its histopathological arterial lesions (with contributions of J. E. Edwards and R. Virmani), the authors described the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::11a8b4813959d0407f40a2cb686ff216
https://pubmed.ncbi.nlm.nih.gov/19702110
https://pubmed.ncbi.nlm.nih.gov/19702110
Publikováno v:
Medicinski pregled. 62
Atherosclerosis is a vascular inflammatory disease resulting from lipid deposition within vascular wall and changes in structure and function of the vascular wall. Atherosclerosis is accelerated when total and LDL cholesterol are elevated and/or HDL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c19452a66f5ddd87a0e29c93b551a7bb
https://pubmed.ncbi.nlm.nih.gov/19702114
https://pubmed.ncbi.nlm.nih.gov/19702114
Autor:
Oliver Schnell, Eberhard Standl, Xavier Cos, Hiddo JL Heerspink, Baruch Itzhak, Nebojsa Lalic, Michael Nauck, Antonio Ceriello
Publikováno v:
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-10 (2020)
Abstract The 5th Cardiovascular Outcome Trial (CVOT) Summit was held in Munich on October 24th–25th, 2019. As in previous years, this summit served as a reference meeting for in-depth discussions on the topic of recently completed and presented CVO
Externí odkaz:
https://doaj.org/article/e4be945d72bb4d2b92d3f8c00d56391f
Autor:
Oliver Schnell, Eberhard Standl, Doina Catrinoiu, Baruch Itzhak, Nebojsa Lalic, Dario Rahelic, Jan Skrha, Paul Valensi, Antonio Ceriello
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-8 (2019)
Abstract The 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group was held in Munich on 25–26 October 2018. As in previous years, this summit served as a reference meeting for in-depth dis
Externí odkaz:
https://doaj.org/article/edff8e1892e84ccc8e56ef808b78e3f8
Autor:
Guntram Schernthaner, Chaim Lotan, Elina Baltadzhieva-Trendafilova, Jonas Ceponis, Martin Clodi, Kristine Ducena, Eva Goncalvesova, Cristian Guja, Marek Honka, Andrej Janež, Nebojša Lalić, Roger Lehmann, Noémi Nyolczas, Priit Pauklin, Andrzej Rynkiewicz, Igor Sergienko, Lea Smirčić Duvnjak
Publikováno v:
Cardiovascular Diabetology, Vol 17, Iss 1, Pp 1-6 (2018)
Abstract Cardiovascular disease (CVD) is the most significant prognostic factor in individuals with type 2 diabetes (T2D). However, a significant number of individuals may develop CVD that does not present with the classic angina-related or heart fai
Externí odkaz:
https://doaj.org/article/f7662e14a56f43069b7ffbdcfeadece8
Autor:
Oliver Schnell, Eberhard Standl, Doina Catrinoiu, Stefano Genovese, Nebojsa Lalic, Katarina Lalic, Jan Skrha, Paul Valensi, Antonio Ceriello
Publikováno v:
Cardiovascular Diabetology, Vol 17, Iss 1, Pp 1-6 (2018)
Abstract The 3rd Cardiovascular Outcome Trial Summit of the Diabetes & Cardiovascular Disease EASD Study Group was held on the 26–27 October 2017 in Munich. As in 2015 and 2016, this summit was organised in light of recently completed and published
Externí odkaz:
https://doaj.org/article/6b7f36a96ddb4742a7560334c420e04f
Autor:
Rafael Gabriel, Nisa Boukichou Abdelkader, Tania Acosta, Aleksandra Gilis-Januszewska, Ricardo Gómez-Huelgas, Konstantinos Makrilakis, Zdravko Kamenov, Bernhard Paulweber, Ilhan Satman, Predrag Djordjevic, Abdullah Alkandari, Asimina Mitrakou, Nebojsa Lalic, Stephen Colagiuri, Jaana Lindström, Jesús Egido, Andrea Natali, J Carlos Pastor, Yvonne Teuschl, Marcus Lind, Luis Silva, Ruy López-Ridaura, Jaakko Tuomilehto, e-PREDICE Consortium
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0231196 (2020)
OBJECTIVES:To assess the effects of early management of hyperglycaemia with antidiabetic drugs plus lifestyle intervention compared with lifestyle alone, on microvascular function in adults with pre-diabetes. METHODS:Trial design: International, mult
Externí odkaz:
https://doaj.org/article/aec0fc9354cb45c686c314a1552ba47c